CDDF Multi-stakeholder workshop (September 2017)

Access to Innovative Oncology Drugs in Europe

Madrid, Spain, 7 & 8 September 2017

CDDF HTA workshop Sept 2017 1200
The CDDF multi-stakeholder workshop on the Access to Innovative Oncology Drugs in Europe aims at facilitating a collaborative discussion between regulatory bodies, HTA organizations, healthcare providers, academics, patients and industry on the challenges of equal access to oncology drugs within and between European countries.

Who should attend?

Representatives from Academia, European Regulatory Bodies (HTA and EMA), Policymakers, Pharmaceutical Industry, Patient Associations and Payers.

twitter32x32Join the discussion on Twitter by using #CDDFworkshop

Workshop details